Search
 
1    2    3    4   
Press Releases
Apr 23, 2014
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
Mar 27, 2014
Generex Announces $2,075,000 Capital Investment
Mar 26, 2014
Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium
All releases
Webcast Events and Media
  Generex Conference Call with Conference Call with Members of the Antigen Express Scientific Advisory Board
- Aug 14, 2013

 
  Generex Investor Conference Call
- Jan 31, 2013

  Second Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference at the New York Academy of Medicine
- Oct 06, 2011


Print Print     Email Email page

News Releases


All Releases
View Summary Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
Apr 23, 2014
PDF 12.1 KB
View Summary Generex Announces $2,075,000 Capital Investment
Mar 27, 2014
PDF 13.0 KB
View Summary Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium
Mar 26, 2014
PDF 10.6 KB
View Summary Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza
Mar 5, 2014
PDF 10.2 KB
View Summary Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients
Feb 27, 2014
PDF 11.4 KB
View Summary Generex/Antigen Express Interview on Clear Channel Business Talk Radio DFW 1190AM by Host Michael Yorba
Feb 12, 2014
PDF 14.2 KB
View Summary Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial
Feb 12, 2014
PDF 12.1 KB
View Summary Generex/Antigen Express "Stock News Now" Interview Available Online
Feb 4, 2014
PDF 10.5 KB
View Summary Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial
Jan 13, 2014
PDF 12.1 KB
View Summary Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference
Jan 9, 2014
PDF 12.5 KB
View Summary Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial
Jan 6, 2014
PDF 11.6 KB
View Summary Antigen Express AE37 Breast Cancer Vaccine Update
Nov 18, 2013
PDF 11.7 KB
View Summary Generex Provides Update on Generex Oral-lyn™ Conference Call
Sep 27, 2013
PDF 11.6 KB
View Summary Generex Announces Publication of Follow-up Studies from Phase I Trial of Novel Immunotherapeutic in Prostate Cancer Patients
Aug 20, 2013
PDF 11.9 KB
View Summary Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy
Aug 13, 2013
PDF 12.0 KB
View Summary Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
Aug 12, 2013
PDF 11.0 KB
View Summary Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board
Jul 23, 2013
PDF 12.8 KB
View Summary Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
Jul 12, 2013
PDF 14.2 KB
View Summary Generex Oral-lyn™ Results in More Rapid Reductions of HbA1c in Shreya's Phase III Study of Type 2 Diabetes in India
Jul 10, 2013
PDF 14.0 KB
View Summary Generex Announces Conference Call with Members of Generex Oral-lyn™ and Diabetes Program Team
Jul 8, 2013
PDF 11.8 KB
View Summary Generex Announces Amendment of Form S-1
Jul 3, 2013
PDF 11.0 KB
View Summary Generex Announces Conference Call with Members of the Antigen Express Scientific Advisory Board
Jul 1, 2013
PDF 10.8 KB
View Summary Generex Announces $1,225,000 Capital Investment
Jun 17, 2013
PDF 12.9 KB
View Summary ASCO Interview of MD Anderson's Mittendorf on AE37 Breast Cancer Vaccine Now Available on Generex Websites
Jun 13, 2013
PDF 9.8 KB
View Summary Generex Announces Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial
Jun 12, 2013
PDF 13.8 KB
View Summary Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients
Jun 5, 2013
PDF 13.7 KB
View Summary Positive Generex Data Underscores Cancer Immunotherapy Forecast Issued by Citi
May 31, 2013
PDF 13.6 KB
View Summary Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
May 22, 2013
PDF 12.4 KB
View Summary Generex Comments on Results of Stockholders` Meeting
Apr 3, 2013
PDF 12.5 KB
View Summary Generex Touts Pipeline Potential of Antigen Express Subsidiary
Feb 7, 2013
PDF 12.6 KB
View Summary Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
Jan 31, 2013
PDF 11.7 KB
View Summary Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
Jan 30, 2013
PDF 13.6 KB
View Summary Generex Announces Details of Investor Conference Call
Jan 29, 2013
PDF 11.3 KB
View Summary Generex Oral-lyn™ Phase III Dossier Submitted To Indian Government For Marketing Approval
Jan 23, 2013
PDF 12.5 KB
View Summary Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
Jan 17, 2013
PDF 14.8 KB
View Summary Generex Announces Investor Conference Call
Jan 11, 2013
PDF 10.7 KB
View Summary Generex Announces $750,000 Capital Investment
Dec 11, 2012
PDF 12.2 KB
View Summary Generex Provides Update on Company Initiatives Including the AE37 Breast Cancer Vaccine Program
Nov 13, 2012
PDF 11.3 KB
View Summary Generex Management Provides Update to Stockholders
Sep 20, 2012
PDF 18.4 KB
View Summary Generex Biotechnology Announces Presentation of Early Results Showing Activity of Cancer Vaccine in Patients with Triple Negative Breast Cancer
Sep 13, 2012
PDF 11.2 KB
Showing 1-40 of 526 Page: 1 2 3 4 5 ... 14  Next 40

Privacy Policy